Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14780962 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL14447237 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL14447399 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL19359634 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL13030308 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL23736061 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL19359635 | 1.00 | EPHX1 (0.50) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL23736062 | 0.97 | SIGMAR1 (0.48) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL16702587 | 0.97 | SIGMAR1 (0.48) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A | |
| SCHEMBL20075957 | 0.97 | SIGMAR1 (0.46) | EPHX1SMN1; SMN2SIGMAR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113831875-B | Insulating adhesive film and preparation method and application thereof | 深圳市纽菲斯新材料科技有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-114181652-B | Insulating adhesive film with low dielectric loss and preparation method and application thereof | 深圳市纽菲斯新材料科技有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-115341296-A | Wear-resistant fiber for clothing and preparation method of fabric of wear-resistant fiber | 创姿服饰(上海)有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-114181652-A | Low-dielectric-loss insulating adhesive film and preparation method and application thereof | 深圳市纽菲斯新材料科技有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-113831875-A | Insulating adhesive film and preparation method and application thereof | 深圳市纽菲斯新材料科技有限公司 | 2021-12-24 | — | — | CN | claimed |
| WO-2020218835-A1 | NOVEL POLYIMIDE-TYPE POLYMER AND PREPARATION METHOD THEREFOR | 서울대학교 산학협력단 | 2020-10-29 | — | — | WO | claimed |
| US-9944593-B2 | Process for the synthesis of fluoralkyl sulfonate salts | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2018-04-17 | — | — | US | claimed |
| CN-101684083-B | Guanidyl alkanoylamino substituted tetracycline derivative | SHANDONG XUANZHU MEDICINE TECHNOLOGY CO LTD | 2011-10-05 | — | — | CN | claimed |
| CN-101759604-A | Guanidyl substitutional tetracycline derivative | SHANDONG XUANZHU PHARM TECH CO | 2010-06-30 | — | — | CN | claimed |
| CN-101684083-A | Guanidyl alkanoylamino substituted tetracycline derivative | SHANDONG XUANZHU MEDICINE TECH | 2010-03-31 | — | — | CN | claimed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | claimed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | claimed |
| EP-0024779-B1 | DRUGS FOR USE WITH INTRAUTERINE DEVICES AND INTRAUTERINE DEVICES CONTAINING SAID DRUGS | Shaw, Seth Thomas, Jr. (US) | 1984-10-17 | — | — | EP | claimed |
| EP-0024780-B1 | MEDICATED INTRAUTERINE DEVICES | Shaw, Seth Thomas, Jr. (US) | 1984-10-17 | — | — | EP | claimed |
| EP-0024781-B1 | MEDICATED INTRAUTERINE DEVICES | Shaw, Seth Thomas, Jr. (US) | 1984-08-08 | — | — | EP | claimed |
| US-4381001-A | A GUANIDINE IN POLYMER MATRIX; ANTIFERTILITY AGENTS AND ANTICOAGULANTS; SUSTAINED RELEASE | SHAW JR SETH T (US) | 1983-04-26 | — | — | US | claimed |
| EP-0024781-A1 | Medicated intrauterine devices | Shaw, Seth Thomas, Jr. (US) | 1981-03-11 | — | — | EP | claimed |
| EP-0024780-A1 | Medicated intrauterine devices | Shaw, Seth Thomas, Jr. (US) | 1981-03-11 | — | — | EP | claimed |
| EP-0024779-A1 | Drugs for use with intrauterine devices and intrauterine devices containing said drugs | Shaw, Seth Thomas, Jr. (US) | 1981-03-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | EPHX1 2359/4885SMN1; SMN2 3508/4885SIGMAR1 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.